| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5574356 | Journal of Stroke and Cerebrovascular Diseases | 2017 | 6 Pages |
Abstract
Patients with supratentorial ICH <30âmL have high rates of poor outcome at 30 days, regardless of location. Nearly 1 in 5 hematomas <30âmL expands, leading to END or death.
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Réza DO, Vivek MD, Daniel A. MD, Christopher H. DO, Luca MD, Catharina J.M. MD, PhD, Craig J. MD, Adrian R. MD, PhD, Mark A. PhD, Brian MD, Joshua Z. MD, MS, Jaime MD, Hipólito MD, Aurel MD, PhD, Ali R. MD, Shaheryar MD, Mario MD,